Wickramasuriya Samiru S, Park Inkyung, Lee Youngsub, Kim Woo H, Przybyszewski Chris, Gay Cyril G, van Oosterwijk Jolieke G, Lillehoj Hyun S
Animal Bioscience and Biotechnology Laboratory, Agricultural Research Service, United States Department of Agriculture, Beltsville, MD, United States.
College of Veterinary Medicine, Institute of Animal Medicine, Gyeongsang National University, Jinju, South Korea.
Front Vet Sci. 2021 Jun 4;8:684818. doi: 10.3389/fvets.2021.684818. eCollection 2021.
Chicken NK-lysin peptide 2 (cNK-2) is a natural lytic peptide with direct cytotoxicity against many apicomplexan parasites including . Developing an effective oral delivery strategy to express cNK-2 in the intestine, where parasites interact with the host's gut epithelial cells, may effectively reduce the fecundity of parasites and minimize intestinal damage. Furthermore, cNK-2 modulates gut immune responses to decrease local inflammation elicited by infection in the intestine. Therefore, we developed a stable strain of () that carries cNK-2 to the gut to determine its effectiveness in ameliorating the negative impacts of coccidiosis and to replace the use of antibiotics in controlling coccidiosis in commercial broiler chicken production. Chickens were randomly allocated into eight treatment groups: two control groups (NC: infected non- control; CON: non-infected control); three empty vector (EV) groups (EV6: 10 cfu/day/bird; EV8: 10 cfu/day/bird; EV10: 10 cfu/day/bird), and three cNK-2 groups (NK6: 10 cfu/day/bird; NK8: 10 cfu/day/bird; NK10: 10 cfu/day/bird). All chickens, except those in the CON group, were challenged with 5,000 freshly sporulated oocysts through oral gavage on day 15. Chickens were given an oral dose of on days 14, 15, and 16. Body weight, weight gains, and fecal oocyst shedding were measured. To investigate the efficacy of oral -cNK-2 against coccidiosis, gene expression of gut health-related biomarkers was measured using RT-PCR. Markers included SOD1, CAT, and HMOX1 for oxidative stress in the spleen and intestinal mucosa, OCLN, ZO-1, and JAM2 for tight junction proteins, and MUC2 for mucin gene expression in the gut. The results showed that oral treatment of young chickens with cNK-2 improved growth performance, enhanced gut integrity, and reduced fecal oocyst shedding. Altogether, these results confirm cNK-2 treatment as a promising and effective alternative strategy to replace antibiotics against coccidiosis based on its ability to reduce parasite survival, to reduce coccidiosis-induced body weight loss, and to decrease gut damage based on the enhanced expression of proteins associated with gut integrity and intestinal health.
鸡NK-溶素肽2(cNK-2)是一种天然裂解肽,对包括……在内的许多顶复门寄生虫具有直接细胞毒性。制定一种有效的口服给药策略,使cNK-2在寄生虫与宿主肠道上皮细胞相互作用的肠道中表达,可能有效降低寄生虫的繁殖力,并将肠道损伤降至最低。此外,cNK-2可调节肠道免疫反应,以减轻肠道感染引起的局部炎症。因此,我们构建了一种稳定的(……)菌株,该菌株可将cNK-2携带至肠道,以确定其在改善球虫病负面影响方面的有效性,并在商业肉鸡生产中替代抗生素用于控制球虫病。将鸡随机分为八个处理组:两个对照组(NC:感染球虫的非转基因对照组;CON:未感染球虫的对照组);三个空载体(EV)组(EV6:10⁶ cfu/天/只鸡;EV8:10⁸ cfu/天/只鸡;EV10:10¹⁰ cfu/天/只鸡),以及三个cNK-2组(NK6:10⁶ cfu/天/只鸡;NK8:10⁸ cfu/天/只鸡;NK10:10¹⁰ cfu/天/只鸡)。除CON组的鸡外,所有鸡在第15天通过口服灌胃接种5000个新鲜孢子化的球虫卵囊。在第14、15和16天给鸡口服一定剂量的(……)。测量鸡的体重、体重增加量和粪便球虫卵囊排出量。为了研究口服-cNK-2对球虫病的疗效,使用逆转录聚合酶链反应(RT-PCR)测量与肠道健康相关生物标志物的基因表达。标志物包括用于检测脾脏和肠道黏膜氧化应激的超氧化物歧化酶1(SOD1)、过氧化氢酶(CAT)和血红素加氧酶1(HMOX1),用于检测紧密连接蛋白的闭合蛋白(OCLN)、紧密连接蛋白1(ZO-1)和连接黏附分子2(JAM2),以及用于检测肠道黏蛋白基因表达的黏蛋白2(MUC2)。结果表明,用cNK-2口服治疗幼鸡可改善生长性能、增强肠道完整性并减少粪便球虫卵囊排出量。总之,这些结果证实,基于cNK-2能够降低寄生虫存活率、减少球虫病引起的体重减轻以及基于与肠道完整性和肠道健康相关蛋白质表达增强而减少肠道损伤的能力,cNK-2治疗是一种有前景且有效的替代策略,可用于替代抗生素治疗球虫病。